The delivery of healthcare is something that Sam Regenstrief was particularly interested in. An inefficient healthcare experience is what led him and his wife Myrtie to found the institute.
Now its research scientists are exploring many avenues to improve care delivery. That includes decision support, symptom management, health communications and precision medicine. Regenstrief faculty are also experts in implementation science and quality measurement, analyzing both the success of interventions designed to improve care delivery and patient outcomes as well as success of the methods by which the intervention was implemented. Much of this work is conducted in partnership with the U.S. Department of Veterans Affairs, giving Regenstrief research scientists a national laboratory to conduct their research.
Many patients suffer from chronic symptoms such as pain, fatigue, insomnia or depression. Regenstrief has contributed to the development of scales and screeners to measure these symptoms, as well as interventions to manage them and improve the lives of those with long or short-term illnesses.
Regenstrief research also seeks to understand the dynamic of patient-provider relationships and the impact of technology, as well as the role of communication in patient outcomes. Handoffs and provider communication are another area of interest.
Implementation research is a relatively new field which examines research itself and how to meaningfully integrate it into practice. Regenstrief investigators and their teams devote their time and talent to understand and remove barriers to getting evidence-based research discoveries into healthcare settings. Regenstrief teams also use data to gain insights into the performance of healthcare systems, plans and interventions. Being able to evaluate care across different settings is the first step in being able to improve healthcare by identifying what works and what doesn’t.
Precision medicine combines prevention and treatment strategies, taking individual patient variables into account. This revolutionary approach to care has the potential to greatly enrich the amount of data available on a single patient and to leverage this data to improve quality of care and patient outcomes.
Related News & Stories
New study provides evidence for three-year interval for multi-target stool DNA screening for those at average risk of colon cancer
A scientific study exploring the appropriate interval for colorectal cancer screening via non-invasive multi-target stool DNA testing for individuals with average risk for the disease reported...
Tailored online personal health record cancer tool increases survivor adherence to national guidelines
Use of the Personal Health Record for Colorectal Cancer Survivors, a new online tool specifically tailored to meet the needs of and make support available for...
Journal editorial: Regenstrief researcher calls for tailoring colorectal cancer screening for 45-to-49-year-olds
It’s been a year since national recommendations issued by the American Cancer Society and the U.S. Multi-Society Task Force called for colorectal cancer (CRC) screening to...